Nutex Health Inc. (NUTX) Cash Flow Statement
Nutex Health Inc. (NUTX) generated $279.6M of operating cash flow over the twelve months to 2026-06-30, spent $5.5M on capital expenditure and had free cash flow of $274.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NUTXNutex Health Inc.Follow NUTX — free
—
Price chart with a free account
- Market cap
- 1.4B
- P/E TTM
- 8.2
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.7 | -0.5 | -0.2 | 0.2 | 0.0 | -0.7 | -0.5 | -4.0 | 86.7 | 173.4 | 50.6 | 1.3 | 23.2 | 248.1 | 279.6 | |
| Capital expenditure | -0.0 | -0.0 | — | -0.0 | -0.0 | — | 0.0 | 0.1 | 61.2 | 36.9 | 14.6 | 9.5 | 2.3 | 2.5 | -5.5 | |
| Free cash flow | -0.7 | -0.5 | — | 0.2 | 0.0 | — | -0.5 | -4.1 | 25.5 | 136.5 | 36.0 | -8.2 | 20.8 | 245.6 | 274.2 | |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 5.0 | — | |
| Stock-based compensation | — | — | — | — | — | 0.9 | 0.2 | 0.5 | 2.6 | 4.0 | 0.2 | — | — | — | — |
USD millions · SEC XBRL
Nutex Health Inc. — questions
- What is Nutex Health Inc.'s operating cash flow?
- $279.6M over the twelve months to 2026-06-30.
- How much does Nutex Health Inc. spend on capital expenditure?
- $5.5M over the twelve months to 2026-06-30.
- What is Nutex Health Inc.'s free cash flow?
- $274.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Nutex Health Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.